Frank Schwoebel

656 total citations
16 papers, 528 citations indexed

About

Frank Schwoebel is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Frank Schwoebel has authored 16 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Frank Schwoebel's work include Iron Metabolism and Disorders (6 papers), Hemoglobinopathies and Related Disorders (3 papers) and Cancer-related molecular mechanisms research (3 papers). Frank Schwoebel is often cited by papers focused on Iron Metabolism and Disorders (6 papers), Hemoglobinopathies and Related Disorders (3 papers) and Cancer-related molecular mechanisms research (3 papers). Frank Schwoebel collaborates with scholars based in Netherlands, Germany and United Kingdom. Frank Schwoebel's co-authors include Stefan Zöllner, Luciana Summo, Kai Riecke, Peter Pickkers, Klaus Buchner, Lucas T. van Eijk, S Vauléon, Werner G. Purschke, Marcel Leist and Dorine W. Swinkels and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Frank Schwoebel

15 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Schwoebel Netherlands 11 223 210 166 76 63 16 528
Adonia E. Papathanassiu United States 8 157 0.7× 275 1.3× 62 0.4× 110 1.4× 48 0.8× 14 552
Ulrike Hebling Germany 10 85 0.4× 176 0.8× 64 0.4× 39 0.5× 31 0.5× 14 392
Marjan Harmsma Netherlands 8 65 0.3× 218 1.0× 30 0.2× 136 1.8× 60 1.0× 8 418
Huihong You United States 10 47 0.2× 274 1.3× 35 0.2× 56 0.7× 70 1.1× 13 522
E. Kurschel Germany 7 49 0.2× 223 1.1× 36 0.2× 78 1.0× 115 1.8× 15 435
Francesca Alvarez‐Calderon United States 9 141 0.6× 239 1.1× 62 0.4× 47 0.6× 65 1.0× 12 438
Ali Memarian Iran 16 43 0.2× 198 0.9× 103 0.6× 370 4.9× 140 2.2× 37 648
Jennifer Tullai United States 8 163 0.7× 138 0.7× 27 0.2× 54 0.7× 79 1.3× 12 333
Hildegard Schmitz-Van de Leur Germany 14 61 0.3× 300 1.4× 92 0.6× 263 3.5× 446 7.1× 18 699

Countries citing papers authored by Frank Schwoebel

Since Specialization
Citations

This map shows the geographic impact of Frank Schwoebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Schwoebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Schwoebel more than expected).

Fields of papers citing papers by Frank Schwoebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Schwoebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Schwoebel. The network helps show where Frank Schwoebel may publish in the future.

Co-authorship network of co-authors of Frank Schwoebel

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Schwoebel. A scholar is included among the top collaborators of Frank Schwoebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Schwoebel. Frank Schwoebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Boyce, Malcolm, Steve Warrington, Stefan Zöllner, et al.. (2016). Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects. British Journal of Pharmacology. 173(10). 1580–1588. 68 indexed citations
2.
Eijk, Lucas T. van, Frank Schwoebel, Luciana Summo, et al.. (2014). Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. Blood. 124(17). 2643–2646. 79 indexed citations
3.
Purschke, Werner G., Kai Hoehlig, Klaus Buchner, et al.. (2014). Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis. Biochemical Journal. 462(1). 153–162. 20 indexed citations
4.
Georgiev, Pencho, Mihaela Lazaroiu, Emanuil Gheorghita, et al.. (2014). Abstract 3847: The anti-hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) as treatment of anemia of chronic disease in patients with multiple myeloma, low grade lymphoma, and CLL: A phase II pilot study. Cancer Research. 74(19_Supplement). 3847–3847. 17 indexed citations
5.
6.
Vater, Axel, Nicolaus Kröger, Stefan Zöllner, et al.. (2013). Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12. Clinical Pharmacology & Therapeutics. 94(1). 150–157. 63 indexed citations
7.
Schwoebel, Frank, Lucas T. van Eijk, Dirk Zboralski, et al.. (2013). The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood. 121(12). 2311–2315. 120 indexed citations
8.
Riecke, Kai, Stefan Zöllner, Malcolm Boyce, et al.. (2012). Single and Repeated Dose First-in-Human Study with the Anti-Hepcidin Spiegelmer Nox-H94.. Blood. 120(21). 2342–2342. 10 indexed citations
9.
10.
Weber, Alexander, et al.. (2011). Optimisation of ITK inhibitors through successive iterative design cycles. Bioorganic & Medicinal Chemistry Letters. 21(6). 1852–1856. 11 indexed citations
11.
12.
13.
Lehner, Martin D., Degenhard Marx, Rainer Boer, et al.. (2006). In Vivo Characterization of the Novel Imidazopyridine BYK191023 [2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3 H-imidazo[4,5-b]pyridine], a Potent and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase. Journal of Pharmacology and Experimental Therapeutics. 317(1). 181–187. 11 indexed citations
14.
Moehrlen, Ueli, et al.. (2005). Early peritoneal macrophage function after laparoscopic surgery compared with laparotomy in a mouse model. Surgical Endoscopy. 19(11). 1516–1516. 1 indexed citations
15.
Lehner, Martin D., Frank Schwoebel, Alexey Kotlyarov, et al.. (2002). Mitogen-Activated Protein Kinase-Activated Protein Kinase 2-Deficient Mice Show Increased Susceptibility to Listeria monocytogenes Infection. The Journal of Immunology. 168(9). 4667–4673. 68 indexed citations
16.
Hentze, Hannes, Frank Schwoebel, Søren Peter Lund, et al.. (2001). In Vivo and in Vitro Evidence for Extracellular Caspase Activity Released from Apoptotic Cells. Biochemical and Biophysical Research Communications. 283(5). 1111–1117. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adonia E. Papathanassiu Breakdown of academic impact, for papers by Ulrike Hebling Breakdown of academic impact, for papers by Marjan Harmsma Breakdown of academic impact, for papers by Huihong You Breakdown of academic impact, for papers by E. Kurschel Breakdown of academic impact, for papers by Francesca Alvarez‐Calderon Breakdown of academic impact, for papers by Ali Memarian Breakdown of academic impact, for papers by Jennifer Tullai Breakdown of academic impact, for papers by Hildegard Schmitz-Van de Leur
Rankless by CCL
2026